Efficacy of Curcumin with Iontophoretic Application on Paw Edema and Hematological Responses in Collagen-Induced Arthritis Rat Models.
Journal
Evidence-based complementary and alternative medicine : eCAM
ISSN: 1741-427X
Titre abrégé: Evid Based Complement Alternat Med
Pays: United States
ID NLM: 101215021
Informations de publication
Date de publication:
2020
2020
Historique:
received:
22
08
2019
revised:
21
01
2020
accepted:
14
02
2020
entrez:
1
5
2020
pubmed:
1
5
2020
medline:
1
5
2020
Statut:
epublish
Résumé
According to previous studies, oral administration of curcumin elucidates anti-inflammatory effect irrespective of its poor bioavailability. This study aims to measure the efficacy of lyophilized curcumin extracts with iontophoresis in arthritic rat models. Lyophilization and characterization of curcumin using the standard HPTLC method was carried out followed by induction of inflammatory arthritis in male albino rats. The animals were then treated with curcumin in three different forms, i.e., oral curcumin (OCU), oral curcumin with topical application (OCU + TOCU), and oral curcumin along with iontophoretically applied curcumin (OCU + IOCU). Various objective variables including body weight, paw edema, arthritic scores, and hematological and biochemical parameters, as well as histopathological examinations were conducted. All the curcumin-treated groups showed significant alleviation of arthritic condition ( Iontophoretic administration of curcumin may ameliorate arthritic symptoms significantly, and the effect is assumed to be due to better penetration and enhanced bioavailability. Geriatrics patients are supposed to be benefited fairly by this technique.
Sections du résumé
BACKGROUND
BACKGROUND
According to previous studies, oral administration of curcumin elucidates anti-inflammatory effect irrespective of its poor bioavailability. This study aims to measure the efficacy of lyophilized curcumin extracts with iontophoresis in arthritic rat models.
METHODS
METHODS
Lyophilization and characterization of curcumin using the standard HPTLC method was carried out followed by induction of inflammatory arthritis in male albino rats. The animals were then treated with curcumin in three different forms, i.e., oral curcumin (OCU), oral curcumin with topical application (OCU + TOCU), and oral curcumin along with iontophoretically applied curcumin (OCU + IOCU). Various objective variables including body weight, paw edema, arthritic scores, and hematological and biochemical parameters, as well as histopathological examinations were conducted.
RESULTS
RESULTS
All the curcumin-treated groups showed significant alleviation of arthritic condition (
CONCLUSIONS
CONCLUSIONS
Iontophoretic administration of curcumin may ameliorate arthritic symptoms significantly, and the effect is assumed to be due to better penetration and enhanced bioavailability. Geriatrics patients are supposed to be benefited fairly by this technique.
Identifiants
pubmed: 32351596
doi: 10.1155/2020/4606520
pmc: PMC7171674
doi:
Types de publication
Journal Article
Langues
eng
Pagination
4606520Informations de copyright
Copyright © 2020 Ahmad Alghadir et al.
Déclaration de conflit d'intérêts
The authors declare that they have no conflicts of interest.
Références
Arthritis Rheum. 1997 Mar;40(3):534-9
pubmed: 9082942
Rheum Dis Clin North Am. 2001 May;27(2):269-81
pubmed: 11396092
Arthritis Res Ther. 2003;5(3):R122-31
pubmed: 12723984
Toxicol Pathol. 1999 Jan-Feb;27(1):134-42
pubmed: 10367688
Biochem Med. 1985 Jun;33(3):320-6
pubmed: 4015632
J Neuroinflammation. 2018 Jan 06;15(1):6
pubmed: 29306322
Crit Rev Ther Drug Carrier Syst. 2004;21(2):97-132
pubmed: 15202928
Int J Inflam. 2018 Jan 15;2018:5023429
pubmed: 29568482
J Rheumatol. 1999 Nov;26(11):2475-9
pubmed: 10555912
Curr Drug Deliv. 2007 Jan;4(1):1-10
pubmed: 17269912
Nat Rev Drug Discov. 2002 Mar;1(3):229-37
pubmed: 12120507
EXCLI J. 2012 May 15;11:226-36
pubmed: 27366139
J Pharm Pharmacol. 1993 Jun;45(6):581-4
pubmed: 7689650
Br J Pharmacol. 2013 Aug;169(8):1672-92
pubmed: 23425071
J Pharm Biomed Anal. 2006 Feb 24;40(3):720-7
pubmed: 16316738
Arthritis Rheum. 2006 Nov;54(11):3452-64
pubmed: 17075840
Evid Based Complement Alternat Med. 2005 Sep;2(3):301-8
pubmed: 16136208
Indian J Med Res. 2011 Sep;134:384-8
pubmed: 21985823
Nutrients. 2019 May 02;11(5):
pubmed: 31052496
Br J Pharmacol. 2011 Feb;162(3):557-65
pubmed: 20860718
BMC Complement Altern Med. 2010 Oct 13;10:56
pubmed: 20939932
Int J Cardiol. 2002 Sep;85(1):89-99
pubmed: 12163213
Ann Rheum Dis. 1972 Jul;31(4):339-43
pubmed: 5045913
J R Soc Med. 2009 Oct;102(10):411-4
pubmed: 19797598
Ann Rheum Dis. 1969 Jan;28(1):35-40
pubmed: 5786280